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Abstract. Carbon ion radiotherapy is a groundbreaking method of treatment radioresistant tumors situated close t  
critical organs. The article presents the physical basis of carbon ion therapy, methods of generation and acceleration of 
heavy ions, systems of forming and exact positioning of the therapeutic beam. Intensity modulated particle herapy and 
raster scanning technique allow optimum compatibiliy between the irradiated volume and target volume. By dint of 
such methods minimum exposure of critical structures is possible. An important aspect of the treatment process is the 
monitoring of patient's position during the irradiation. It is possible by means of the modern imaging techniques such as 
PET-CT. Increase of the availability of heavy ion therapy and its development are big challenges for the physicists of the 
most prestigious research centers in the world.  
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INTRODUCTION 
The main advantage of carbon ions compared to 
conventional beams such as X-rays, gamma rays, high 
energy photons, electrons is different depth dose 
distribution. The Bragg maximum at the end of the 
particle range allows the application of higher dose f 
radiation to the tumor and protect normal tissues. 
PHYSICAL BASIS OF HADRON 
THERAPY 
Heavy ions, passing through the irradiated tissue, 
lose energy during multiple acts of ionization and slow 
down. This process is described by Bethe-Bloch 
formula from 1930. Ions, which penetrate the matter 
with high speed, leave a small portion of their energy 
in one interaction. Consequently, the radiation dose 
deposited at the beginning of path is relatively low. If 
the ions penetrate deeper, they will move slower and 
lose more energy to processes of ionization. 
Transferred dose reaches the highest value - Bragg 
maximum at the end of ions path. Although the ions 
have a finite range, the dose tail is observed behind the 
Bragg peak. Its source is the ionization processes 
caused by fragments of nuclear matter and neutrons, 
which were created as a result of carbon ions collisi ns 
with atomic nuclei of medium. Carbon ions are 
characterized by high energy transfer at the end of 
distance traveled in a material medium, which is 
extremely desirable in teleradiotherapy. In contrast to 
photon radiation, for which maximum dose is a few 
centimeters below the skin surface and decreases 
exponentially with increasing depth, heavy ions 
provide the highest radiation dose in the Bragg peak 
region (Fig. 1). It is possible to give ions an 
appropriate initial energy, so that maximum energy 
transfer takes place precisely in the area of the tumor, 
and damage to adjacent healthy tissues are minimal. 
 
 
FIGURE 1. Dose distribution for 12C ions and photons [1]. 
  
45 
Carbon ions are particles with greater mass and higher 
charge than protons so they have sharper Bragg peak, 
higher linear energy transfer (LET) and thus higher 
relative biological effectiveness (RBE). The RBE 
reaches the maximum in the target volume but it is 
sufficiently low in the plateau before the Bragg peak. 
INDICATIONS FOR CARBON ION 
THERAPY 
Carbon ions, due to the high ionization density in 
the Bragg peak region, cause multiple DNA damages, 
even in the most radioresistant pathological cells. 
Therefore patients with radioresistant tumors situated 
in the vicinity of sensitive organs are primarily 
referred to the carbon ion therapy. This type of therapy  
is used to treat cancers of head, neck, bone, prostate, 
uterus, rectum, liver and lung [2]. The scope of 
applicability of the carbon ion therapy is still 
increasing.   
TECHNICAL ASPECTS CARBON ION 
THERAPY 
Compact sources, based on the effect of Electron 
Cyclotron Resonance (ECR), are frequently used to 
obtain ion beams. Furthermore scientists aim at the 
development of LDIA technique (laser-driven ion 
acceleration), which  uses laser with high power (50 or 
100 TW), variable phase and short pulses (20 fs) as the 
injector of synchrotron [3]. Afterward carbon ions are 
accelerated by cyclotron or synchrotron, so that their 
kinetic energies ranged between 80 and 430 MeV/u, 
which corresponds to the depth of body penetration 
between 2 and 30 cm. Heavy ion beam is aimed at 
target by a gantry, which rotates around the patient and 
allows the irradiation of planning target volume from 
different directions with high accuracy. Maximum 
deviation is 0.5 mm [4]. Due to the high cost of gantry 
construction more common is to use horizontal fixed 
beam treatment rooms. The Bragg peak of a 
monoenergetic ion beam is too narrow to be used in 
therapy. It must be extended to cover the tumor 
volume of different size and shape. Superposition of 
Bragg peaks is called the SOBP region (Spread-Out 
Bragg Peak). In the earlier technical solutions a 
therapeutic beam was formed by passive system, based 
on such elements as range modulators, compensators 
and wedges. Nowadays the following modern 
irradiation techniques are used: intensity-modulated 
particle radiotherapy (IMPT) and raster scanning. 
Intensity-controlled raster scan allows a three-
dimensional irradiation of the subdivided into voxels 
target volume. Each of the tumor spatial elements is 
irradiated separately by ions of a appropriate energy, 
depending on the depth of the layer. Deflection of the 
ion beam is performed using variable magnetic fields 
produced by electromagnets. The beam is focused onto 
a specific volume element until the desired dose is 
reached. As a result the dose is delivered to the tumor 
with a millimeter precision. During the irradiation 
patient is immobilized and his position is monitored. 
The range and location of the carbon ion beam can be 
tracked inside the patient in real time by dint of 
positron emission tomography (PET). Positron 
emitters such as 10C, 11C and 15O are created as a result 
of carbon ions collision with atoms of the tissue [5].  
During the cancer treatment process on average patint 
receives 13 fractions of radiation spread over three 
weeks [2]. 
PERSPECTIVES 
An extremely important aspect of radiation therapy 
is the problem of moving targets in the thorax and the 
abdominal region. Known techniques, such as gating 
(synchronization of irradiation and breathing) 
and multi-painting (repeated irradiation) are still 
imperfect [6]. Therefore the development of the 
respiratory gated scanning method is a challenge for 
physicist from research centers worldwide. 
CONCLUSION 
Carbon ion therapy opens new perspectives in the 
struggle against cancer because of inverse depth dose 
profile (maximum dose at the end of the range), large 
linear energy transfer and radiobiological effectiveness 
in the region of Bragg peak, reduction in treatment 
time and maximum protection of normal tissues. 
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